Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Generic Drugs	582.36M	466.68M	-	-
Generic Drugs Growth	24.79%	-	-	-
Pharmaceuticals	-	-	316.63M	212.47M
Pharmaceuticals Growth	-	-	49.03%	-
Total	582.36M	466.68M	316.63M	212.47M
Total Growth	24.79%	47.39%	49.03%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Mainland China	582.36M	466.68M	316.63M	212.47M
Mainland China Growth	24.79%	47.39%	49.03%	-
Total	582.36M	466.68M	316.63M	212.47M
Total Growth	24.79%	47.39%	49.03%	-

Source: S&P Global Market Intelligence.